CLR 125

· Cellectar Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLR 125, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of CLR 125 in Triple Negative Breast Cancer [Phase 1]